Does ANAKINRA Cause Stent placement? 59 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Stent placement have been filed in association with ANAKINRA (Kineret). This represents 0.5% of all adverse event reports for ANAKINRA.
59
Reports of Stent placement with ANAKINRA
0.5%
of all ANAKINRA reports
27
Deaths
56
Hospitalizations
How Dangerous Is Stent placement From ANAKINRA?
Of the 59 reports, 27 (45.8%) resulted in death, 56 (94.9%) required hospitalization, and 41 (69.5%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAKINRA. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does ANAKINRA Cause?
Off label use (4,317)
Drug ineffective (3,368)
Pain (1,344)
Condition aggravated (1,339)
Rheumatoid arthritis (1,300)
Drug intolerance (946)
Joint swelling (921)
Injection site pain (879)
Product dose omission issue (864)
Arthralgia (850)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which ANAKINRA Alternatives Have Lower Stent placement Risk?
ANAKINRA vs ANAMORELIN
ANAKINRA vs ANASTROZOLE
ANAKINRA vs ANDEXANET ALFA
ANAKINRA vs ANDROGEL
ANAKINRA vs ANETHOLTRITHION